Insider Transactions in Q2 2024 at 4 D Molecular Therapeutics, Inc. (FDMT)
Insider Transaction List (Q2 2024)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Jun 24
2024
|
David Kirn Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
12,930
-1.21%
|
$297,390
$23.1 P/Share
|
|
Jun 24
2024
|
David Kirn Chief Executive Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
12,930
+1.19%
|
$181,020
$14.42 P/Share
|
|
Jun 17
2024
|
Scott Bizily Chief Legal Officer |
SELL
Open market or private sale
|
Direct |
1,750
-50.19%
|
$40,250
$23.71 P/Share
|
|
Jun 17
2024
|
Scott Bizily Chief Legal Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
1,750
+22.33%
|
$12,250
$7.27 P/Share
|
|
May 16
2024
|
Scott Bizily Chief Legal Officer |
SELL
Open market or private sale
|
Direct |
1,750
-28.99%
|
$43,750
$25.55 P/Share
|
|
May 16
2024
|
Scott Bizily Chief Legal Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
1,750
+22.33%
|
$12,250
$7.27 P/Share
|
|
Apr 16
2024
|
Scott Bizily Chief Legal Officer |
SELL
Open market or private sale
|
Direct |
1,750
-50.19%
|
$43,750
$25.74 P/Share
|
|
Apr 16
2024
|
Scott Bizily Chief Legal Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
1,750
+22.33%
|
$12,250
$7.27 P/Share
|
|
Apr 01
2024
|
Scott Bizily Chief Legal Officer |
SELL
Open market or private sale
|
Direct |
8,153
-82.44%
|
$252,743
$31.78 P/Share
|
|
Apr 01
2024
|
Scott Bizily Chief Legal Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
8,153
+24.8%
|
$97,836
$12.64 P/Share
|